Stephanie Hatch
Senior Research Scientist
Stephanie joined the HTS group in April 2016. She is responsible for developing and running high throughput screens, including ELISAs and various cellular phenotypic screens. Previously she performed cell-based assays as part of the Structural Genomic Consortium. She obtained her PhD from the University of North Carolina, Chapel Hill.
Recent publications
-
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Journal article
Emmenegger M. et al, (2023), iScience
-
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Journal article
Vihta KD. et al, (2022), Clin Infect Dis, 75, e329 - e337
-
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Journal article
Wei J. et al, (2022), Nat Commun, 13
-
Automated 96-well format high throughput colony formation assay for siRNA library screen.
Journal article
Hatch SB. et al, (2022), STAR Protoc, 3
-
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Journal article
Wei J. et al, (2022), Nat Med, 28, 1072 - 1082